Citadel Advisors’s Revolution Healthcare Acquisition Corp. SAIL Warrant. REVHW Stock Holding History

Citadel Advisors’s Portfolio REVHW Stock Details REVHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200,001	Closed	-$8K	–	15915
2022 Q3	$8K	Hold	200,001	–	–	﹤0.01%	12321
2022 Q2	$50K	Hold	200,001	–	–	﹤0.01%	11945
2022 Q1	$90K	Sell	200,001 -200,000	-50%	-$108K	﹤0.01%	12387
2021 Q4	$300K	Buy	400,001 +125,352	+46%	+$105K	﹤0.01%	10928
2021 Q3	$257K	Buy	274,649 +74,549	+37%	+$85K	﹤0.01%	11423
2021 Q2	$280K	Buy	+200,100	New	+$255K	﹤0.01%	11437

Other funds holding REVHW

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Citadel Advisors's REVHW Position: Q4 2022 in Review

Citadel Advisors sold out of Revolution Healthcare Acquisition Corp. SAIL Warrant. (REVHW) in Q4 2022, closing a stake of 200,001 shares — an estimated $8K sold.

Citadel Advisors first reported a position in REVHW in Q2 2021 and held it in 6 quarters. The position peaked at $300K in Q4 2021. 1 fund tracked by Wall St. Rank holds REVHW as of Q4 2022.

Citadel Advisors reported no remaining Revolution Healthcare Acquisition Corp. SAIL Warrant. position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 200,001 Revolution Healthcare Acquisition Corp. SAIL Warrant. shares in Q4 2022, an estimated $8K.
Citadel Advisors first reported a position in Revolution Healthcare Acquisition Corp. SAIL Warrant. in Q2 2021 and held it in 6 quarters.
Citadel Advisors's Revolution Healthcare Acquisition Corp. SAIL Warrant. position peaked at $300K in Q4 2021.
1 fund tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Warrant. as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.